Boichot E, Biyah K, Germain N, Emonds-Alt X, Lagente V, Advenier C
Laboratoire de Pharmacodynamie, Faculté des Sciences Pharmaceutiques et Biologiques, Université de Rennes 1, France.
Eur Respir J. 1996 Jul;9(7):1445-50. doi: 10.1183/09031936.96.09071445.
Tachykinins, such as substance P, might be involved in the development of airway hyperresponsiveness (AHR) and airway inflammation. However, it is unknown which tachykinin receptors mediate these biological activities. The effects of two antagonists of tachykinin neurokinin-1 (NK1) and tachykinin neurokinin-2 (NK2) receptors, SR 140333 and SR 48968, respectively, were investigated on substance P (SP)-induced airway hyperresponsiveness and potentiation of the histamine-induced increase in microvascular leakage, in phosphoramidon-pretreated guinea-pigs. Guinea-pigs were pretreated with phosphoramidon (0.1 mM aerosol for 15 min) and exposed 15 min later to saline solution alone or to saline solution containing SP (0.1 mg.mL-1 for 30 min). Twenty four hours later, the animals were anaesthetized and prepared for the recording of the pulmonary inflation pressure (PIP) to acetylcholine or for the investigation of microvascular leakage to histamine. Pretreatment of the guinea-pigs with a single dose of SR 48968 (1 mg.kg-1, i.p.) 30 min before SP exposure, significantly prevented the development of AHR, whereas SR 140333 (1 mg.kg-1, i.p.) did not. In a second set of experiments, phosphoramidon-pretreated guinea-pigs exposed to SP presented a significant potentiation of the histamine-induced increase in microvascular leakage in pulmonary airways. When the guinea-pigs were pretreated with SR 140333, an inhibition of the increased microvascular leakage to histamine was observed. In contrast, no significant inhibitory activity was noted when the guinea-pigs were pretreated with SR 48968. The present data demonstrate the importance of tachykinin NK2 receptor stimulation in the development of airway hyperresponsiveness and that of tachykinin NK1 receptor stimulation in microvascular leakage hypersensitivity in phosphoramidon-pretreated and substance P-exposed guinea-pigs. The results also suggest a dissociation between the presence of microvascular leakage and the occurrence of airway hyperresponsiveness.
速激肽,如P物质,可能参与气道高反应性(AHR)和气道炎症的发生发展。然而,尚不清楚哪种速激肽受体介导这些生物学活性。分别研究了速激肽神经激肽-1(NK1)和神经激肽-2(NK2)受体的两种拮抗剂SR 140333和SR 48968对经磷酰胺预处理的豚鼠中P物质(SP)诱导的气道高反应性以及组胺诱导的微血管渗漏增加的增强作用的影响。豚鼠用磷酰胺(0.1 mM气雾剂,持续15分钟)预处理,15分钟后单独暴露于盐溶液或含有SP(0.1 mg/mL,持续30分钟)的盐溶液。24小时后,将动物麻醉并准备记录对乙酰胆碱的肺充气压力(PIP)或研究对组胺的微血管渗漏情况。在暴露于SP前30分钟,用单剂量的SR 48968(1 mg/kg,腹腔注射)预处理豚鼠,可显著预防AHR的发生,而SR 140333(1 mg/kg,腹腔注射)则无此作用。在另一组实验中,经磷酰胺预处理并暴露于SP的豚鼠,其肺气道中组胺诱导的微血管渗漏增加有显著增强。当豚鼠用SR 140333预处理时,可观察到对组胺诱导的微血管渗漏增加的抑制作用。相反,当豚鼠用SR 48968预处理时,未观察到明显的抑制活性。目前的数据表明,在经磷酰胺预处理并暴露于P物质的豚鼠中,速激肽NK2受体刺激在气道高反应性的发生发展中起重要作用,而速激肽NK1受体刺激在微血管渗漏超敏反应中起重要作用。结果还提示微血管渗漏的存在与气道高反应性的发生之间存在分离现象。